The 10-day moving average for PTN crossed bullishly above the 50-day moving average on February 20, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PTN's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 72 cases where PTN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on February 06, 2025. You may want to consider a long position or call options on PTN as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PTN just turned positive on February 07, 2025. Looking at past instances where PTN's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where PTN advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .
PTN moved below its 50-day moving average on February 21, 2025 date and that indicates a change from an upward trend to a downward trend.
The Aroon Indicator for PTN entered a downward trend on February 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PTN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.977) is normal, around the industry mean (12.481). P/E Ratio (0.000) is within average values for comparable stocks, (84.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). PTN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (52.083) is also within normal values, averaging (251.221).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
a developer of peptide, peptide mimetic and small molecule agonist compounds
Industry Biotechnology
A.I.dvisor indicates that over the last year, PTN has been loosely correlated with FATE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PTN jumps, then FATE could also see price increases.
Ticker / NAME | Correlation To PTN | 1D Price Change % | ||
---|---|---|---|---|
PTN | 100% | -1.96% | ||
FATE - PTN | 41% Loosely correlated | -8.09% | ||
KRYS - PTN | 33% Poorly correlated | +2.87% | ||
MDGL - PTN | 32% Poorly correlated | -4.22% | ||
VTGN - PTN | 30% Poorly correlated | +2.09% | ||
AVCTF - PTN | 30% Poorly correlated | N/A | ||
More |